Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06111690 · ClinicalTrials.gov registry record · NA

Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement

A NA study of Knee Osteoarthritis, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT06111690 is a NA study of Knee Osteoarthritis that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 16 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06111690, a NA study of Knee Osteoarthritis, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The aim is to demonstrate that preoperative exercises (prehabilitation) using blood-flow restriction training (BFRT) is safe, well tolerated, improves muscle function, decreases functional limitation, and increases physical activity in older adults awaiting total knee replacement (TKR).

Conditions Studied

Interventions

  • PROCEDURE Blood Flow Restriction Training (BFRT)

Study Locations (1)

Texas

  • UT Health San Antonio- Dept. of Physical Therapy - San Antonio

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2022-09-23
Est. Completion 2024-12-02
Phase NA

What the Registry Record Tells You About NCT06111690

The ClinicalTrials.gov registry entry for NCT06111690 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (95% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Blood Flow Restriction Training (BFRT) is the first listed.

NCT06111690 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06111690 about?

NCT06111690 is a clinical study titled "Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement". The aim is to demonstrate that preoperative exercises (prehabilitation) using blood-flow restriction training (BFRT) is safe, well tolerated, improves muscle function, decreases functional limitation, and increases physical activity in older adults awaiting total knee replacement (TKR).

What is the current status of trial NCT06111690?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-09-23. Estimated completion is 2024-12-02.

What conditions does trial NCT06111690 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT06111690?

The interventions under investigation include: Blood Flow Restriction Training (BFRT) (PROCEDURE).

Who is sponsoring clinical trial NCT06111690?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06111690 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.